Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24079,983,1.17 [1.06-1.28],0.0014458528410724
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23992,195,1.58 [1.28-1.95],2.253351510834356e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25991,192,1.42 [1.15-1.76],0.0013147537418802
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18361,760,1.37 [1.23-1.54],2.6912886245541515e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25924,125,1.51 [1.16-1.97],0.0021159774961747
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24861,78,1.36 [0.98-1.88],0.0699503712939273
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27356,124,1.49 [1.15-1.95],0.0029907700934625
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27351,84,1.21 [0.88-1.67],0.2391782901802115
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24247,64,2.13 [1.48-3.07],5.3847024783486334e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26687,116,1.30 [0.99-1.70],0.0584261245979687
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26638,67,1.51 [1.07-2.15],0.0205511905776987
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27438,75,0.81 [0.58-1.13],0.2070141465460957
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27403,99,1.30 [0.97-1.74],0.0831804822165229
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27398,94,1.31 [0.96-1.77],0.0841881974518361
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27060,61,1.19 [0.82-1.73],0.3588453029256867
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26263,438,1.14 [0.99-1.32],0.06355944718611
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25955,130,1.41 [1.09-1.82],0.0090987180956796
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26130,305,1.08 [0.92-1.28],0.352426107644224
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22456,51,1.13 [0.75-1.70],0.5721621366742096
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22465,60,nan [nan-nan],
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22663,258,0.96 [0.87-1.07],0.4678498035840208
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22671,266,nan [nan-nan],
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23068,663,1.11 [0.99-1.25],0.0742923953061333
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22457,52,1.18 [0.78-1.78],0.4310983854898901
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24609,1010,1.28 [1.17-1.41],1.9351687041210133e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26365,292,0.88 [0.74-1.04],0.1352117429967138
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27099,109,0.86 [0.65-1.14],0.2843616563448716
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27532,89,0.94 [0.69-1.28],0.6950246108007982
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27318,59,0.83 [0.57-1.22],0.3428169831663614
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27534,68,0.87 [0.61-1.24],0.4455060788501132
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Stomach,27579,53,0.78 [0.52-1.15],0.2049007662141179
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27359,272,0.96 [0.81-1.15],0.6823540049261212
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27529,109,0.91 [0.69-1.21],0.5157854108828113
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27528,106,1.24 [0.93-1.65],0.1392154454074436
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27461,69,1.03 [0.72-1.47],0.8710420194289693
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",27463,68,1.01 [0.71-1.45],0.9358656863425446
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,27365,262,0.84 [0.70-1.01],0.060223581042304
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27539,118,0.84 [0.64-1.09],0.1923255333692181
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,27427,226,0.88 [0.73-1.07],0.2035670888363238
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of breast,27517,138,1.02 [0.79-1.31],0.8983990973272701
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,27013,992,1.02 [0.93-1.12],0.7287782383607553
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26177,269,1.25 [1.05-1.50],0.0133232234382923
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25908,436,1.21 [1.05-1.40],0.007003320837727
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25908,436,1.21 [1.05-1.40],0.007003320837727
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24367,406,1.35 [1.16-1.56],6.608793503105163e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27011,95,1.23 [0.91-1.66],0.1763958484804177
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27225,108,0.87 [0.66-1.15],0.3309463914410383
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22874,908,1.15 [1.04-1.27],0.0068215287256648
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25250,895,1.07 [0.97-1.18],0.1914996026702454
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25730,114,2.54 [1.94-3.33],1.0155325012911316e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26572,59,1.10 [0.75-1.61],0.6169304397064036
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25720,104,2.34 [1.77-3.10],3.2675229710151037e-09
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26026,410,1.64 [1.41-1.90],5.543782755383585e-11
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26017,401,1.61 [1.38-1.86],4.722900345327998e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25502,195,1.07 [0.86-1.35],0.5307509535678802
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25505,192,1.08 [0.86-1.36],0.4926387806190887
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22680,714,1.11 [0.99-1.24],0.0712803568896082
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22047,81,1.47 [1.06-2.03],0.0194330705511894
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22628,662,1.10 [0.98-1.24],0.1150742054239725
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22016,50,0.98 [0.65-1.49],0.940555771662135
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22037,71,1.56 [1.10-2.21],0.0130809319884473
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,23276,618,1.17 [1.04-1.32],0.0096240061676025
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22775,117,1.14 [0.86-1.51],0.3675686172833766
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27341,79,1.03 [0.73-1.45],0.8681693041254208
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27382,48,1.02 [0.66-1.59],0.9171131981429068
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26144,38,1.24 [0.76-2.02],0.3851679702513637
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27531,38,1.24 [0.76-2.02],0.383846292510689
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22696,38,1.25 [0.76-2.04],0.3756640004560561
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Alcohol dependence,26131,25,1.39 [0.76-2.54],0.2778594288344492
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,26029,34,1.41 [0.85-2.35],0.1858822659146711
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22701,43,0.80 [0.52-1.23],0.3114081031310155
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23040,382,1.20 [1.03-1.39],0.021347899228234
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression,25586,340,1.20 [1.02-1.41],0.0245709569253966
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,22823,299,1.20 [1.01-1.42],0.0392824562908976
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22805,147,1.31 [1.03-1.67],0.0305953622047296
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,25661,73,1.04 [0.74-1.48],0.8072005844121468
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,23759,1623,1.13 [1.05-1.22],0.0014003472567576
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21732,180,0.94 [0.75-1.17],0.587637757971753
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27383,151,0.89 [0.70-1.13],0.3571847094506689
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26234,415,1.20 [1.04-1.39],0.0120674335580422
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,25955,136,1.60 [1.25-2.05],0.0002184519714687
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,25944,125,1.03 [0.79-1.35],0.8023462641908194
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27133,116,1.02 [0.77-1.34],0.9011903643529068
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26876,57,1.00 [0.68-1.48],0.9947046378648188
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,25912,93,1.07 [0.80-1.45],0.6438899559490854
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27160,65,1.21 [0.85-1.73],0.292810163077151
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26190,857,1.09 [0.99-1.21],0.092933483014793
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25452,119,0.95 [0.73-1.24],0.701641426358033
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25883,550,1.10 [0.97-1.24],0.152876709236523
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27317,75,1.43 [1.02-2.00],0.0362609901645487
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,27299,57,1.54 [1.05-2.26],0.0274829797213817
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27090,125,1.28 [0.99-1.67],0.0630832966875651
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26837,422,1.19 [1.03-1.37],0.0193084637480435
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26662,247,1.12 [0.93-1.36],0.2166168556544951
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26485,70,1.03 [0.73-1.47],0.8532322334210891
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26547,132,0.90 [0.70-1.16],0.4323531714046709
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26521,106,1.35 [1.01-1.79],0.0397975011889789
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23433,180,1.22 [0.98-1.52],0.0733807993342929
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23666,413,1.08 [0.93-1.25],0.3039863308261838
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26529,179,1.27 [1.02-1.58],0.0324673406940687
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27312,33,1.97 [1.20-3.23],0.0075364421122706
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1774,33,1.83 [1.14-2.96],0.0130197232685386
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25571,33,1.99 [1.21-3.27],0.0067707799688967
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26883,92,0.99 [0.73-1.35],0.9616682844394776
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26843,52,0.92 [0.61-1.38],0.6821338405045102
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26744,97,0.98 [0.73-1.33],0.9193019607934568
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27003,101,1.27 [0.95-1.70],0.1053426295701162
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27455,129,1.10 [0.85-1.42],0.4818697503248741
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26781,104,1.02 [0.77-1.37],0.8677627440536104
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20310,2789,1.12 [1.05-1.20],0.0005251693372225
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27000,76,1.14 [0.81-1.60],0.444183533109887
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21325,2047,1.07 [0.99-1.15],0.0803564309370411
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,21347,2069,1.07 [1.00-1.15],0.0552109327666575
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19325,47,2.08 [1.36-3.17],0.0007064108952283
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25898,729,1.21 [1.08-1.36],0.0007369948772604
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,25676,507,1.15 [1.01-1.31],0.0379531838729376
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26908,153,1.15 [0.90-1.45],0.2647370097326965
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26987,232,1.31 [1.08-1.59],0.0068545559048305
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27509,27,1.49 [0.84-2.64],0.1718586061839176
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25266,97,1.69 [1.26-2.28],0.0005374001195407
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25636,479,1.24 [1.08-1.42],0.0020036298522881
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26791,99,1.24 [0.93-1.66],0.145955929603249
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26893,218,1.35 [1.11-1.65],0.0026953281932071
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26790,98,1.45 [1.08-1.95],0.014464732286144
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26790,98,1.45 [1.08-1.95],0.014464732286144
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19373,95,1.45 [1.07-1.97],0.0162836768120908
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23956,39,1.07 [0.67-1.70],0.78833764348537
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,23994,77,1.08 [0.77-1.51],0.639647116729747
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16567,102,1.14 [0.85-1.52],0.3971915919549502
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16744,279,1.35 [1.12-1.63],0.0013739043383148
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,23967,50,1.31 [0.87-1.98],0.1962498011112649
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23974,57,1.38 [0.94-2.04],0.1043401041262726
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26737,100,1.42 [1.06-1.90],0.0186004326853117
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26790,127,1.87 [1.44-2.42],2.151502029806073e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26832,96,1.91 [1.42-2.56],1.878497773256561e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26903,84,1.91 [1.39-2.62],6.135418560407799e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26596,69,1.14 [0.80-1.64],0.4566600097265387
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26639,112,1.39 [1.06-1.83],0.0188505976533548
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25958,132,1.53 [1.18-1.97],0.0010909949869051
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25931,105,1.45 [1.09-1.93],0.0104370196233063
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27368,102,1.43 [1.07-1.91],0.014915494312311
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,26433,607,1.01 [0.90-1.14],0.8503962012825699
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,26431,92,1.46 [1.07-2.00],0.0156194484441637
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22410,2105,1.08 [1.01-1.15],0.0279634778203705
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27365,126,1.09 [0.84-1.41],0.5115787084477563
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25938,203,1.35 [1.10-1.66],0.0043198642864416
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25918,183,1.22 [0.98-1.52],0.0770702907155614
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26679,229,1.08 [0.89-1.31],0.4475274246942216
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26671,221,1.09 [0.89-1.33],0.3905507080242978
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26810,564,0.96 [0.84-1.08],0.4719171095631975
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26362,116,0.81 [0.62-1.05],0.1115733770672957
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,26326,80,0.94 [0.68-1.30],0.7060735594582084
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26599,353,0.91 [0.78-1.07],0.2533688337322942
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26388,142,0.84 [0.66-1.08],0.1732736516896085
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13293,64,0.96 [0.66-1.38],0.8120637346702322
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24621,1166,1.08 [0.98-1.18],0.1072530475269565
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,26523,155,0.86 [0.68-1.09],0.2067389571686047
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26543,175,0.86 [0.69-1.08],0.1980241866903127
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26543,175,0.86 [0.69-1.08],0.1980241866903127
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25518,1003,1.08 [0.98-1.18],0.1270132619172859
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,20489,1003,1.10 [1.00-1.21],0.0523123182398438
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20297,1003,1.11 [1.00-1.22],0.0401466434803242
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20473,987,1.10 [1.00-1.21],0.0478547729660149
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27251,84,1.67 [1.22-2.29],0.0013342265760697
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,25788,63,1.86 [1.30-2.67],0.0007403079851077
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27327,63,1.84 [1.28-2.65],0.0009312402761848
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25781,56,1.82 [1.24-2.67],0.0020610999071764
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,25735,89,1.38 [1.02-1.88],0.0391972773924486
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,25839,193,1.44 [1.17-1.78],0.0006832091358051
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26410,91,1.47 [1.08-2.00],0.014887823624133
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19086,6001,1.04 [1.00-1.09],0.0763167064887672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27008,473,0.95 [0.83-1.08],0.4350932089667608
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27532,104,0.93 [0.70-1.24],0.6317001723173481
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,27537,93,0.90 [0.66-1.21],0.4774861104196332
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,26641,106,0.88 [0.67-1.16],0.3790209397744467
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26653,118,0.97 [0.74-1.28],0.852261026151327
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27524,115,0.98 [0.74-1.28],0.8613743865878419
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26652,117,0.90 [0.69-1.18],0.4520026078292292
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26349,78,1.08 [0.78-1.50],0.6484697655104458
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27442,49,0.82 [0.55-1.24],0.3534219044343695
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20849,223,1.06 [0.87-1.30],0.5364522828218168
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22950,2324,1.04 [0.97-1.11],0.2807222945964578
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,20915,289,0.90 [0.75-1.07],0.2210161089456372
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21371,745,1.05 [0.94-1.18],0.3450256396644722
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20705,79,1.18 [0.85-1.65],0.3216090575106572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20761,135,0.99 [0.77-1.28],0.9670031091133044
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20666,40,0.72 [0.46-1.14],0.1594506453434387
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,20774,148,1.09 [0.86-1.39],0.4835193042113438
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20702,76,1.04 [0.74-1.45],0.829463612349902
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27487,54,1.17 [0.79-1.75],0.437016059863559
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,20762,136,1.26 [0.98-1.62],0.0731033999453981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21467,841,1.04 [0.94-1.16],0.4513291632939326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27415,145,0.74 [0.59-0.94],0.0135123702685774
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21204,578,1.01 [0.89-1.14],0.8977447130793355
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20807,181,0.99 [0.79-1.23],0.9161005431229762
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27448,142,0.92 [0.72-1.17],0.4836333291519166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27387,117,0.68 [0.53-0.87],0.0025550965371153
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,24690,1194,0.97 [0.89-1.06],0.5516809957718329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,23562,66,1.28 [0.88-1.84],0.1943827491070331
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23567,71,0.85 [0.61-1.19],0.3358817482860934
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,23600,104,0.96 [0.72-1.28],0.8014465106535005
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24453,957,0.96 [0.87-1.06],0.3922700431992756
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26484,911,1.11 [1.00-1.22],0.0414945599317836
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21823,2187,1.05 [0.98-1.12],0.1459337709577356
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27224,63,1.27 [0.87-1.86],0.2143774664248378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27504,91,1.34 [0.98-1.84],0.0635987206018862
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,25664,91,1.35 [0.99-1.85],0.0591454288637737
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25640,67,1.39 [0.96-2.00],0.0777331607997899
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27427,133,1.27 [0.98-1.64],0.0665402003481335
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,25706,133,1.27 [0.99-1.65],0.0637017506275067
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25692,119,1.26 [0.96-1.66],0.0920053463905112
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26345,772,1.10 [0.99-1.23],0.0723411371779251
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26334,761,1.10 [0.99-1.22],0.0888893425630928
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19745,109,1.02 [0.77-1.36],0.889376415477495
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal stricture,27099,109,1.02 [0.77-1.35],0.9100917445765092
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19704,68,0.92 [0.64-1.32],0.6337212093704757
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20305,669,0.99 [0.88-1.12],0.8866045703616456
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19878,242,1.04 [0.86-1.27],0.6576434939329312
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20031,395,1.15 [0.99-1.34],0.0696214354026941
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,25861,352,1.16 [0.99-1.35],0.0709116441169329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27054,125,1.31 [1.01-1.70],0.0453537193273696
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19761,125,0.88 [0.67-1.14],0.3232714107279456
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19681,45,0.90 [0.58-1.39],0.6272115980436161
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20520,884,1.09 [0.98-1.20],0.1118058690844945
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19868,232,0.97 [0.80-1.18],0.7544091310353076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27036,107,1.45 [1.10-1.93],0.0096808874324707
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,26785,106,1.19 [0.90-1.59],0.2292000588071291
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,26734,55,1.04 [0.70-1.54],0.8593469186076714
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25997,882,1.11 [1.00-1.23],0.0439944257288035
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,25851,736,1.05 [0.94-1.17],0.4177449002584956
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,25247,132,1.07 [0.83-1.38],0.6185827486614375
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25186,71,1.37 [0.97-1.95],0.0745491695974199
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25177,62,1.34 [0.92-1.94],0.1229538981073701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27416,62,1.33 [0.92-1.92],0.1319206130785699
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26175,310,1.33 [1.12-1.58],0.0010075529000476
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25968,103,1.59 [1.20-2.12],0.0013775682312318
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,25953,88,1.71 [1.25-2.35],0.0008979418090695
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25906,41,1.60 [1.01-2.54],0.0463722230435873
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26036,171,1.12 [0.89-1.41],0.3285997752388494
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,26026,161,1.11 [0.88-1.40],0.3877969506294542
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24415,1616,1.01 [0.94-1.09],0.7288195318134507
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27111,115,1.03 [0.78-1.35],0.8382975912004221
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27112,455,0.92 [0.80-1.05],0.2288891104214451
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25994,697,1.11 [0.99-1.24],0.0784020831863367
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26761,325,1.13 [0.96-1.33],0.1470041380994568
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26507,71,0.88 [0.63-1.24],0.474960930406611
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26645,209,1.22 [1.00-1.50],0.0511831718123821
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27286,89,0.89 [0.66-1.21],0.4684276264400318
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27262,65,0.80 [0.56-1.14],0.2120552408004381
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27248,51,0.78 [0.52-1.15],0.2086034587309522
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27300,53,1.06 [0.71-1.59],0.7828318350872542
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27297,50,1.02 [0.67-1.55],0.9181992764952416
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26713,56,1.17 [0.79-1.72],0.4427166125900625
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27016,359,0.91 [0.78-1.06],0.2308092045545894
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25402,105,0.96 [0.72-1.29],0.8004881164343055
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25453,156,1.03 [0.81-1.30],0.8176118218350906
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25410,113,0.94 [0.71-1.24],0.6616352744909626
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25551,254,1.14 [0.95-1.38],0.1579859333837796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25527,230,1.14 [0.94-1.38],0.1988788918441024
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19431,4406,1.11 [1.05-1.17],0.0001113423305019
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21172,2539,1.08 [1.01-1.15],0.0251775920004972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24759,1333,1.08 [0.99-1.17],0.0670159148561204
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18846,213,1.31 [1.07-1.60],0.0098656448204871
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19157,524,1.23 [1.08-1.40],0.0021354158096525
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26994,204,1.27 [1.03-1.56],0.0224361696712294
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27011,186,1.33 [1.07-1.65],0.0098779390277505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19861,1228,1.04 [0.95-1.14],0.3983148263946501
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22568,1228,1.05 [0.96-1.15],0.2844757027614008
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18645,12,1.06 [0.47-2.44],0.8822087535508254
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27375,12,1.09 [0.48-2.51],0.8345583108005388
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18915,282,1.11 [0.93-1.33],0.2557494621799214
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18720,87,0.98 [0.71-1.34],0.881794020121704
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18942,309,1.08 [0.91-1.29],0.3659888098481396
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27370,156,1.06 [0.84-1.34],0.6215119372752063
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19111,478,1.12 [0.97-1.29],0.109379826949485
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19123,490,1.05 [0.92-1.21],0.4520744493754293
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20052,1419,1.06 [0.98-1.15],0.1692518728436446
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18741,108,1.17 [0.88-1.56],0.2864153634230268
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19056,423,0.95 [0.82-1.10],0.5272612218968816
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18716,83,0.79 [0.58-1.09],0.152690969620868
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18738,105,0.98 [0.73-1.31],0.8789796452855407
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19004,371,1.02 [0.87-1.19],0.8033260326849048
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18949,316,1.09 [0.92-1.29],0.3062123728429997
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20560,301,1.25 [1.05-1.48],0.0099197751142145
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26754,220,1.66 [1.36-2.01],3.57627754238386e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26626,92,1.45 [1.07-1.97],0.0157494919394425
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23597,81,1.02 [0.74-1.42],0.8846833806484505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23822,306,1.13 [0.95-1.34],0.1607747086696256
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24542,1026,1.09 [0.99-1.20],0.0749218335700038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23731,215,1.12 [0.91-1.37],0.2786461878120693
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23595,79,1.27 [0.92-1.77],0.1500854073262956
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24330,814,1.09 [0.98-1.21],0.1162866858279609
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23568,52,1.06 [0.70-1.59],0.7966346588606927
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23755,239,1.08 [0.89-1.31],0.4264587366420329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23617,101,1.07 [0.80-1.44],0.6316471313100633
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23606,90,0.84 [0.62-1.14],0.2585028586014919
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23679,163,1.16 [0.92-1.46],0.1965472782756276
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23590,74,0.99 [0.71-1.39],0.9719415285259836
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23865,349,1.10 [0.94-1.28],0.2580472393193738
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23810,384,1.01 [0.87-1.17],0.9212655111650508
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23500,74,1.00 [0.71-1.41],0.996083876394702
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23538,112,1.41 [1.07-1.86],0.0158482411113287
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23566,140,0.75 [0.59-0.96],0.0196258988335452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23465,39,1.12 [0.70-1.81],0.6305569128797168
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23484,58,1.31 [0.89-1.93],0.1741556443726516
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23469,43,1.05 [0.67-1.65],0.8380651496998003
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23705,279,1.06 [0.89-1.26],0.5294063633269919
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23485,59,1.11 [0.76-1.63],0.5771583391676451
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23494,68,0.99 [0.70-1.41],0.9722645188692326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23566,140,0.95 [0.74-1.21],0.6590785906153649
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23505,79,1.13 [0.81-1.57],0.4853721677386954
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23962,536,1.16 [1.02-1.32],0.0242221057698289
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23616,190,1.01 [0.82-1.25],0.922985583248038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23714,288,1.18 [1.00-1.41],0.0559142670320797
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24818,237,1.31 [1.08-1.59],0.0055280149778624
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25065,484,1.18 [1.03-1.35],0.0180484891175221
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24621,40,1.19 [0.75-1.91],0.4620309367676796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24646,65,0.85 [0.60-1.23],0.392655778048143
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24695,114,0.96 [0.73-1.26],0.7558931679490507
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22499,6112,0.99 [0.95-1.04],0.7556193578549193
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25113,198,1.52 [1.23-1.87],8.405707157540862e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24958,43,1.32 [0.84-2.07],0.2308831419234946
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25289,36,1.87 [1.16-3.01],0.0106677245595871
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25298,45,2.20 [1.43-3.38],0.000316299464606
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25293,40,2.06 [1.30-3.26],0.001988628735662
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27331,132,0.89 [0.69-1.15],0.3855048919463215
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27214,64,1.91 [1.33-2.73],0.0004576683167594
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27298,99,0.85 [0.64-1.14],0.2860607178821187
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27237,38,0.88 [0.55-1.40],0.5809054495330681
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25340,1257,0.98 [0.90-1.06],0.5840990081505326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,24220,137,0.98 [0.76-1.26],0.8912882459072778
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24171,88,1.21 [0.89-1.66],0.2250738480490319
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24251,168,0.93 [0.74-1.16],0.5109860160372053
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24172,89,0.90 [0.66-1.22],0.4905819077481033
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25072,989,0.98 [0.89-1.07],0.6020117541978349
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27254,470,0.99 [0.87-1.14],0.925599894141764
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26929,145,1.13 [0.88-1.45],0.3265805755598135
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26950,166,1.08 [0.85-1.35],0.5366563323741329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26894,110,0.86 [0.65-1.14],0.3019388516702925
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27194,555,0.87 [0.77-0.99],0.0329697284020267
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26772,133,0.82 [0.64-1.05],0.1212635466499753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26886,247,0.86 [0.72-1.04],0.1173653805193295
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25130,4572,0.96 [0.92-1.01],0.1046360591375376
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20919,361,0.86 [0.74-1.01],0.0649320953249934
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20654,96,1.10 [0.82-1.49],0.5230835196054976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20725,167,0.75 [0.60-0.94],0.0115449795914852
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21353,795,0.87 [0.78-0.97],0.010154904778295
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20963,405,0.87 [0.75-1.01],0.0625819036308371
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21514,956,1.02 [0.93-1.13],0.6498633077852491
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20874,316,1.06 [0.90-1.26],0.46888154269354
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20996,438,0.99 [0.86-1.15],0.9379642937435644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20656,98,1.05 [0.78-1.42],0.752414129953519
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20745,187,0.87 [0.70-1.08],0.1990821785031706
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27532,264,0.87 [0.73-1.04],0.1181337506200256
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27544,251,0.85 [0.71-1.02],0.0761027925894971
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27570,140,0.83 [0.65-1.06],0.1361121396980571
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27559,153,0.87 [0.69-1.10],0.2343100319211315
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20704,146,0.88 [0.69-1.13],0.3202796017532269
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20674,116,0.94 [0.72-1.24],0.6660957482022334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20701,143,1.03 [0.81-1.32],0.7865174051039026
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27463,466,0.92 [0.80-1.05],0.2094848279974693
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21890,1332,0.96 [0.89-1.05],0.3757480757349509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21424,866,0.97 [0.88-1.08],0.5912667178513343
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27549,196,0.94 [0.76-1.16],0.5549013712243218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21023,465,0.95 [0.83-1.09],0.4892150375860604
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20881,323,1.04 [0.88-1.22],0.6660195546976126
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21444,886,1.03 [0.93-1.14],0.528332995335637
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female infertility,20674,116,0.94 [0.71-1.24],0.6469169115690263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20667,109,0.93 [0.70-1.24],0.6327420989883142
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27565,878,0.96 [0.86-1.07],0.4568573769888577
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27571,1197,0.97 [0.88-1.07],0.592841999013404
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27567,476,0.88 [0.77-1.01],0.0666590803743162
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27228,137,0.87 [0.67-1.12],0.2681767823127947
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27281,190,0.73 [0.60-0.90],0.0033760516359999
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27253,162,1.07 [0.85-1.35],0.5642337698776358
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27585,163,1.09 [0.87-1.38],0.4558644137339196
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27587,160,1.09 [0.86-1.38],0.474829034855351
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27583,421,1.01 [0.87-1.17],0.8813025995733175
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27290,128,1.08 [0.83-1.40],0.5682171981099209
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27393,231,0.99 [0.82-1.21],0.9590265847834724
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26834,147,1.07 [0.83-1.37],0.6172238322711427
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26889,202,0.91 [0.74-1.12],0.3757719803896716
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26939,252,1.06 [0.88-1.28],0.5386605422205066
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26834,147,0.85 [0.66-1.09],0.1942543071093041
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26825,138,0.92 [0.72-1.19],0.5386753637216531
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26836,149,0.92 [0.72-1.17],0.4849563662479097
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26604,230,0.93 [0.76-1.14],0.501962446141992
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26811,437,1.03 [0.89-1.20],0.6633880701088999
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27043,669,1.00 [0.88-1.13],0.938503550835156
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27588,169,0.93 [0.74-1.18],0.5612901167087614
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26129,128,0.95 [0.73-1.23],0.7048256402228399
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26477,103,1.13 [0.84-1.52],0.4304206865841825
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27596,340,0.89 [0.76-1.05],0.1756538174405054
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27516,260,0.82 [0.68-0.99],0.0383647864195543
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27583,253,1.02 [0.85-1.24],0.8115975586525648
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27573,243,1.04 [0.86-1.26],0.6837414688164664
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27295,45,1.41 [0.92-2.17],0.1160551395265937
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24673,639,0.99 [0.88-1.12],0.8785211497473109
